New treatment option studied for blood cancer patients in china
NCT ID NCT05013190
Summary
This study observes Chinese adults with multiple myeloma who switch from their initial treatment to a medication called ixazomib. Researchers will follow about 80 patients for up to 2 years to see how well the treatment works and what side effects occur. The goal is to understand real-world outcomes when patients change to this different medication regimen.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, 010050, China
-
Anhui Cancer Hospital
Hefei, Anhui, 230000, China
-
Beijing Chao-Yang Hospital,Capital Medical University
Beijing, Beijing Municipality, 100020, China
-
Beijing Jishuitan Hospital
Beijing, Beijing Municipality, 100096, China
-
Henan Province People Hospital
Zhengzhou, Henan, 450004, China
-
Qingdao Municipal Hospital
Qingdao, Qingdao, 266071, China
-
Shengjing Hospital affiliated to China Medical University
Shenyang, Liaoning, 110022, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital of Zhenzhou University
Zhengzhou, Henan, 450052, China
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300052, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.